| ¿µ¹® | vaccine | ÇÑ±Û | ¹é½Å |
|---|---|---|---|
| ¼³¸í | Àü¿°º´¿¡ ´ëÇÏ¿© ÀΰøÀûÀ¸·Î ¸é¿ªÀ» ÁÖ±â À§ÇØ »ýü¿¡ Åõ¿©ÇÏ´Â Ç׿øÀÇ Çϳª. º´¿øÃ¼ ¹× µ¶¼Ò¿¡ ´ëÇÑ ¹æ¾î±â±¸¸¦ °ÈÇÒ ¸ñÀûÀ¸·Î »ç¿ëµÇ´Â ¹Ì»ý¹°Á¦Á¦¸¦ ¸»ÇÑ´Ù. ÇÁ¶û½ºÀÇ ¹Ì»ý¹°ÇÐÀÚ L. ÆÄ½ºÅ𸣿¡ ÀÇÇÏ¿© Á¦Ã¢µÈ ¿ë¾î·Î¼, ¾î¶² °¨¿°Áõ¿¡ ´ëÇÏ¿© ÀΰøÀûÀ¸·Î ¸é¿ªÀ» ¾ò±â À§ÇÏ¿© ±× º´¿ø ¹Ì»ý¹° ¶Ç´Â ±× µ¶¼Ò¾×¿¡ Àû´çÇÑ Á¶ÀÛÀ» °¡ÇÏ¿© ¸¸µç °ÍÀ» ¸»ÇÑ´Ù. |
||
| FLAIR | fluid attenuated inversion recovery |
|---|---|
| DEV | Duck Embryo Vaccine |
| HBPV | Haemophilus influenza type B Polysaccharide(PRP) Vaccine; BÇü Çì¸ðÇʷ罺 ÀÎÇ÷翣ÀÚ ÇǸ· ´Ù´çÁú ¹é½Å... |
| HDCV | Human Diploid Cell Vaccine; Àΰ£ À̹èü ¼¼Æ÷ ¹é½Å |
| NTV | Nervous Tissue Vaccine; ½Å°æ Á¶Á÷ ¹é½Å |
| RLO | Rickettsia-like organisms |
|---|---|
| ATR | Attenuated Total Reflectance |
| ATR-FTIR | Attenuated Total Reflectance Fourier-Transform Infrared |
| ATR | Attenuated Total Reflection |
| ATR-FTIR | Attenuated total reflection Fourier transform infrared |
| attenuated vaccine | Live pathogens that have lost their virulence but are still capable of inducing a protective immune response to the virulent forms of the pathogen, e.g., Sabin polio vaccine. (05 Mar 2000) |
|---|---|
| rickettsia vaccine | Attenuated See: typhus vaccine. (05 Mar 2000) |
| attenuated | <microbiology, virology> To reduce the virulence (infectivity) of a pathogenic microorganism. (27 Sep 1997) |
| attenuated tuberculosis | A mild chronic form marked by caseous tubercles of the skin and the occurrence of cold abscesses. (05 Mar 2000) |
| attenuated virus | A weakened virus that is no longer virulent. Can be used to make a live virus vaccine. (12 Dec 1998) |
| vaccines, attenuated | Live vaccines prepared from microorganisms which have undergone physical adaptation (e.g., by radiation or temperature conditioning) or serial passage in laboratory animal hosts or infected tissue/cell cultures, in order to produce avirulent mutant strains capable of inducing protective immunity. (12 Dec 1998) |
| rickettsia | A member of a group of microorganisms that (like viruses) require other living cells for growth but (like bacteria) use oxygen, have metabolic enzymes and cell walls, and are susceptible to antibiotics. Rickettsiae cause a series of diseases (see rickettsial diseases). (12 Dec 1998) |
| Rickettsia akari | A species causing human rickettsialpox; transmitted by the house mouse mite, Liponyssoides sanguineus; a mild febrile disease of 7 to 10 days is produced with an urban distribution in the northeastern U.S. And in wild or commensal rodents in the countries of the former USSR and Africa. (05 Mar 2000) |
| Rickettsia australis | A species causing a spotted fever, North Queensland tick typhus, clinically and serologically similar to the disease caused by the agent of rickettsialpox; Ixodes holocyclus and I. Tasmani are probable vectors. Small marsupials are suspected reservoirs of this agent, which is found over much of coastal Queensland, especially in secondary scrub and savannah. (05 Mar 2000) |
| Rickettsia burnetii | Former name for Coxiella burnetii. (05 Mar 2000) |
| Rickettsia canis | Former name for Ehrlichia canis. (05 Mar 2000) |
| Rickettsia conorii | A widespread African species probably causing boutonneuse fever in humans, transmitted by various ticks, such as the dog tick Rhipicephalis sanguineus, as well as ticks serve as the reservoir of human infection. (05 Mar 2000) |
| rickettsia infections | Infections by the genus rickettsia. (12 Dec 1998) |
| Rickettsia mooseri | A species similar to Rickettsia prowazekii but with less variation in appearance; the resultant endemic typhus is milder and has a somewhat slower onset. (05 Mar 2000) |
| rickettsia prowazekii | A species of gram-negative, aerobic bacteria that is the aetiologic agent of epidemic typhus fever acquired through contact with lice (typhus, epidemic louse-borne) as well as brill's disease. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|